Non-PTLD Malignancy post HSCT in patients with Primary Immunodeficiency: UK experience

Publication date: Available online 7 March 2018
Source:Journal of Allergy and Clinical Immunology
Author(s): Mohamed Najib Mohamed Unni, Reem Elfeky, Kanchan Rao, Zohreh Nademi, Robert Chiesa, Persis Amrolia, Roderick Skinner, Olga Slater, Austen Worth, Terence Flood, Mario Abinun, Sophie Hambleton, Waseem Qasim, Hubert B. Gaspar, Andrew J. Cant, Andrew R. Gennery, Paul Veys, Mary A. Slatter
Secondary malignancy post haematopoietic stem cell transplantation (HSCT) for malignant disorders is well recognized. There are very few published reports on malignancy post HSCT for Primary Immunodeficiency (PID). We report 12 cases of 944 patients, who developed non-PTLD malignancy post-HSCT for PID.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2IcC1sB